09 03-2026 Glaukos Celebrates 3 Million Implants Worldwide, Reinforcing Commitment to Surgeons and Patients Across Asia-Pacific Glaukos proudly celebrates a significant global milestone—more than 3 million interventional glaucoma implants worldwide – highlighting the company’s transformative impact on the treatment of glaucoma. As the pioneer of Micro-Invasive Glaucoma Surgery (MIGS), Glaukos has helped redefine the glaucoma treatment paradigm by introducing innovative, dropless platforms designed to improve clinical outcomes and help preserve vision […] Read More
29 05-2024 Reviscon Mono 2% – a one time injectable solution for osteoarthritis pain and mobility issues